Journal ArticleDOI
Exploring natural compounds for the management of non-small cell lung cancer
TLDR
A growing incidence of drug resistance and tumour proliferation in non-small cell lung cancer escalates the urge for potential lead molecules, and the plant-derived natural compounds have played a role in the development of these molecules.About:
This article is published in Natural Product Research.The article was published on 2020-07-29. It has received 1 citations till now. The article focuses on the topics: Lung cancer.read more
Citations
More filters
Journal ArticleDOI
Natural products: Potential targets of TME related long non-coding RNAs in lung cancer
Rama Rao Malla,Vasudeva Raju Padmaraju,Rakshmitha Marni,Mohammad Amjad Kamal,Mohammad Amjad Kamal +4 more
TL;DR: In this article, a combination of TME and lung CSCs, lncRNAs and enrichment and stemness maintenance were identified as potential therapeutic targets, aiming to develop natural product-based therapeutics to treat metastatic and drug-resistant lung cancers.
References
More filters
Journal ArticleDOI
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray,Jacques Ferlay,Isabelle Soerjomataram,Rebecca L. Siegel,Lindsey A. Torre,Ahmedin Jemal +5 more
TL;DR: A status report on the global burden of cancer worldwide using the GLOBOCAN 2018 estimates of cancer incidence and mortality produced by the International Agency for Research on Cancer, with a focus on geographic variability across 20 world regions.
Journal ArticleDOI
Natural product and natural product derived drugs in clinical trials
TL;DR: The next few years will be critical for NP-driven lead discovery, and a concerted effort is required to identify new biologically active pharmacophores and to progress these and existing compounds through pre-clinical drug development into clinical trials.
Journal ArticleDOI
A Comprehensive Docking and MM/GBSA Rescoring Study of Ligand Recognition upon Binding Antithrombin
TL;DR: The results have demonstrated that it is very important to keep a few top poses for rescoring, if the binding is non-specific or the binding mode is not well determined by the docking calculation.
Journal ArticleDOI
Structure-based discovery of a novel inhibitor targeting the β-catenin/Tcf4 interaction.
Wang Tian,Xiaofeng Han,Xiaofeng Han,Maocai Yan,Yan Xu,Yan Xu,Srinivas Duggineni,Srinivas Duggineni,Nan Lin,Nan Lin,Guifen Luo,Guifen Luo,Yan Michael Li,Xiaobing Han,Xiaobing Han,Ziwei Huang,Ziwei Huang,Jing An,Jing An +18 more
TL;DR: Down-regulation of c-Myc and cyclin D1 expression, the two important effectors of the Wnt/β-catenin signaling, is confirmed by treating HCT116 cells with BC21, a new and modifiable potential anticancer candidate that targets β- catenin/Tcf-4 interaction.
Journal ArticleDOI
Discovery of small molecule inhibitors of the Wnt/β-catenin signaling pathway by targeting β-catenin/Tcf4 interactions.
Maocai Yan,Guanqun Li,Jing An +2 more
TL;DR: This paper reviews the currently reported inhibitors that target β-catenin/Tcf4 interactions, focusing on the discovery approaches taken in the design of these inhibitors and their bioactivities.
Related Papers (5)
Role of Indole Scaffolds as Pharmacophores in the Development of Anti-Lung Cancer Agents.
Jyothi Dhuguru,Rachid Skouta +1 more